Status:
COMPLETED
CGM Use in Preterm Infants
Lead Sponsor:
University of Minnesota
Conditions:
Very Low Birth Weight Infant
Very Preterm Maturity of Infant
Eligibility:
All Genders
Up to 72 years
Brief Summary
Preterm infants (gestational age (GA) at birth \< 31 weeks) admitted to the University of Minnesota Masonic Children's Hospital NICU will have a Dexcom G6 sensor Continuous Glucose Monitor (CGM) place...
Eligibility Criteria
Inclusion
- preterm infants (gestational age (GA) at birth \< 31 weeks)
- admitted to the University of Minnesota Masonic Children's Hospital Neonatal Intensive Care Unit
- written informed consent can be secured from a parent within 96 hours of birth.
Exclusion
- Infants born at ≥31 weeks GA
- infants with a prenatally diagnosed clinical or genetic condition (other than prematurity) that is known to affect growth rate, adiposity, or neurocognitive development
- children experiencing severe birth asphyxia,
- children enrolled in another nutritional study,
- children likely to be transferred out of the NICU
Key Trial Info
Start Date :
October 3 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 14 2025
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT05436925
Start Date
October 3 2022
End Date
August 14 2025
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455